Terance Kinninger

Terry Kinninger has over 30 years of senior executive experience in international technology companies both publicly traded and privately held in the medical diagnostics, medical device, software and information technology industries. Terry has raised over $250 million through IPO’s, private equity and debt financings, and has extensive mergers & acquisition experience with transactions totaling over $700 million. Prior to joining Agena Bioscience, Terry was CFO & COO of Estech, and prior to that CFO & Executive VP Business Development of R2 Technology. Terry has also served as COO & CFO of Bridge Medical; CFO & Senior VP Operations of MetaCreations; CFO & Senior VP Corporate Development of Delphi Information Systems; and CFO of Integral Systems and WebSideStory. Early in his career, Terry was a CPA with PricewaterhouseCoopers and holds a BS from Miami University, Ohio.